SCHEMBL6802299

SCHEMBL6802299

COc1cc(-c2cc(=O)c3ccc(OC)c(OC)c3o2)cc(OC)c1OC(C)=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.63
CYP3A4 P08684 2/20 0.63
CYP2C19 P33261 2/20 0.63
NCOA1 Q15788 1/20 0.63
NCOA3 Q9Y6Q9 1/20 0.63
TERT O14746 7/20 0.61
CYP1A1 P04798 3/20 0.58
CYP1B1 Q16678 2/20 0.58
PABPC1 P11940 1/20 0.54
TUBB4A P04350 1/20 0.52
TUBB P07437 1/20 0.52
TUBA3C P0DPH7 1/20 0.52
TUBA1B P68363 1/20 0.52
TUBA4A P68366 1/20 0.52
TUBB4B P68371 1/20 0.52
TUBB3 Q13509 1/20 0.52
TUBB2A Q13885 1/20 0.52
TUBB8 Q3ZCM7 1/20 0.52
TUBA3E Q6PEY2 1/20 0.52
TUBA1A Q71U36 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6797692 0.85 CYP3A4 (0.66) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL988001 0.82 TERT (0.77) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL29612043 0.82 TERT (0.77) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL6808412 0.81 ADORA3 (0.58) CYP3A4TERTALDH1A1MAPTHPGD
SCHEMBL6618586 0.80 TUBB4A (0.60) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL4649487 0.80 CYP3A4 (0.76) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL6613755 0.79 TERT (0.77) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL6612282 0.79 TUBB4A (0.76) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL31438670 0.79 TERT (0.67) CYP1A2CYP3A4CYP2C19NCOA1NCOA3
SCHEMBL12556183 0.79 CYP1A1 (0.51) CYP1A2CYP3A4CYP2C19NCOA1NCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 US disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP CYP1A2 3159/4885CYP3A4 3385/4885CYP2C19 3703/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP CYP1A2 3209/4885CYP3A4 3411/4885CYP2C19 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.